Abstract
The exhaled breath condensate is a source of biomarkers with many advantages and benefits compared to other traditional sampling techniques in respiratory medicine. It is a biological product that is formed by cooling the exhaled air via its guidance through a condenser. It is characterized as a cocktail of volatile and non-volatile compounds with water being the predominant constituent. Its composition presents a non-uniformed structure as the volatile and the non-volatile compounds vary in type and ratio. All these compounds originate from the whole respiratory tract. Some of them fulfil the criteria to be characterized as biomarkers since there is a similarity between the content of the exhaled breath condensate and the respiratory tract lining fluid. In addition, the potential biomarkers of the exhaled breath condensate and those from other biological fluids are equivalent.
Advantages and Disadvantages Its place in the respiratory medicine as a matrix of biomarkers relies on its various strengths. Some of them are very important and make it exceptional regarding its application, such as its totally non-invasive character and its usage in all ages, while others present a more potential action regarding its purpose such as the categorization of respiratory diseases. However, there are limitations in its application due to the lack of standardization of its conduct which can be minimized by following the official recommendations. Additional studies are needed to develop said standardization.
Aim The aim of this paper is to present a brief and comprehensive picture of the sampling technique of the exhaled breath condensate, as well as the criteria to make it a preferred choice as a source of biomarkers.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ahmadzai H, Huang S, Hettiarachchi R, Lin JL, Thomas PS, Zhang Q (2013) Exhaled breath condensate: a comprehensive update. Clin Chem Lab Med 51(7):1343–1361
Bajaj P, Ishmael FT (2013) Exhaled breath condensates as a source for biomarkers for characterization of inflammatory lung disease. J Anal Sci Methods Instrum 3:17–29
Balbi B, Pignatti P, Corradi M, Baiardi P, Bianchi L, Radaeli A, Moscato G, Mutti A, Spanevello A, Malerba M (2007) Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults. Eur Respir J 30(4):769–781
Beck O, Oliln AC, Mirgorodskaya E (2016) Potential of mass spectrometry in developing clinical laboratory biomarkers of nonvolatiles in exhaled breath. Clin Chem 62(1):84–91
Carter SR, Davis CS, Kovacs EJ (2012) Exhaled breath condensate collection in the mechanically ventilated patient. Respir Med 106:601–613
Chhabra SK, Gupta M (2012) Exhaled breath condensate analysis in chronic obstructive pulmonary disease. Indian J Chest Dis Allied Sci 54:27–37
Davis MD, Montpetit A, Hunt J (2012) Exhaled breath condensate – an overview. Immunol Allergy Clin N Am 32(3):363–375
Dodig S, Cepelak I (2013) Exhaled breath condensate – from an analytical point of view. Biochem Med 23(3):281–295
Esther CR, Boucher RC, Johnson MR, Ansede JH, Donn KH, O’Riordan TG, Ghio AJ, Hirsh AJ (2014) Airrway drug pharmacokinetics via analysis of exhaled breath condensate. Pulm Pharmacol Ther 27:76–82
Harshman SW, Grigsby CC, Ott DK (2014) Exhaled breath condensate for proteomic biomarker discovery. Chromatography 1:108–119
Haslbeck K, Schwarz K, Hohlfeld JM, Seume JR, Koch W (2010) Submicron droplet formation in the human lung. J Aerosol Sci 41:429–438
Hayes SA, Haefliger S, Harris B, Pavlakis N, Clarke SJ, Molloy MP, Howell VM (2016) Exhaled breath condensate for lung cancer protein analysis: a review of methods and biomarkers. J Breath Res 10:034001. https://doi.org/10.1088/1752-7155/10/3/034001
Horváth I, Loukides S, Barnes PJ, Högman M, Sterk PJ et al (2017) A European Respiratory Society technical standard: exhaled biomarkers in lung disease. Eur Respir J 49:1600965. https://doi.org/10.1183/13993003.00965-2016
Hunt J (2011) Condensing exhaled breath into science. Chest 139(1):5–6
Konstantinidi EM, Lapas AS, Tzortzi AS, Behrakis PK (2015) Exhaled breath condensate: technical and diagnostic aspects. Sci World J:435160, 25. https://doi.org/10.1155/2015/435160
Kuban P, Foret F (2013) Exhaled breath condensate: determination of non-volatile compounds and their potential clinical diagnosis and monitoring. A review. Anal Chim Acta 805:1–18
Liang Y, Yeligar SM, Brown LA (2012) Exhaled breath condensate: a promising source for biomarkers of lung diseases. Sci World J:217518, 7. https://doi.org/10.1100/2012/217518
Lim MY, Thomas PS (2013) Biomarkers in exhaled breath condensate and serum of chronic obstructive pulmonary disease and non-small-cell lung cancer. Int J Chronic Dis:578613, 15. https://doi.org/10.1155/2013/578613
Loukides S, Kontogianni K, Hillas G, Horvath I (2011) Exhaled breath condensate in asthma: from bench to bedside. Curr Med Chem 18:1432–1443
Maniscalco M, Motta A (2017) Metabolomics of exhaled breath condensate: a means for phenotyping respiratory diseases? Biomark Med 11(6):405–407
Rahimpour E, Khoubnasabjafari M, Jouyban-Gharamaleki V, Jouyban A (2018) Non-volatile compounds in exhaled breath condensate: re view of methodological aspects. Anal Bioanal Chem 410:6411. https://doi.org/10.1007/s00216-018-1259-4
Rattray NJW, Hamrang Z, Trivedi DK, Goodacre R, Fowler SJ (2014) Taking your breath away: metabolics breathes life in to personalized medicine. Trends Biotechnol 32(10):538–548
Roca O, Masclans JR (2012) Exhaled breath condensate in critically III mechanically ventilated patients. Clin Pulm Med 19(2):84–89
Rosias P (2012) Methodological aspects of exhaled breath condensate collection and analysis. J Breath Res 6:027102
Zamuruyev KO, Aksevon AA, Pasamontes A, Brown JF, Pettit DR, Foutouhi S, Weimer BC, Schivo M, Kenyon NJ, Delplanque JP, Davis CE (2017) Human breath metabolomics using an optimized non-invasive exhaled breath condensate sampler. J Breath Res 11:016001
Zimmerman JJ (2012) Exhaled breath condensate: A breathalyzer for lung inflammation. Pediatr Crit Care Med 13(2):212–214
Παναγιωτοπούλου – Γαρταγάνη Π, Σακελλαροπούλου Α, Μηλίγκος Β, Λαγκώνα Ε (2009) Μη επεμβατικοί μέθοδοι αξιολόγησης της φλεγμονής των αεραγωγών στο παιδικό άσθμα. Ann Clin Paediatr 56(3):481–488
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this paper
Cite this paper
Patsiris, S., Exarchos, T., Vlamos, P. (2020). Exhaled Breath Condensate (EBC): Is It a Viable Source of Biomarkers for Lung Diseases?. In: Vlamos, P. (eds) GeNeDis 2018. Advances in Experimental Medicine and Biology, vol 1195. Springer, Cham. https://doi.org/10.1007/978-3-030-32633-3_2
Download citation
DOI: https://doi.org/10.1007/978-3-030-32633-3_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-32632-6
Online ISBN: 978-3-030-32633-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)